Abstract: (1) Background and (2) Methods: A 14-day in vivo, multitoxic (pure mycotoxins) rat experiment was conducted with zearalenone (ZEA; 15 µg/animal/day), deoxynivalenol (DON; 30 µg/animal/day) and fumonisin B 1 (FB 1 ; 150 µg/animal/day), as individual mycotoxins, binary (FD, FZ and DZ) and ternary combinations (FDZ), via gavage in 1 mL water boluses. (3) Results: Body weight was unaffected, while liver (ZEA↑ vs. DON) and kidney weight (ZEA↑ vs. FDZ) increased. Hepatocellular membrane lipid fatty acids (FAs) referred to ceramide synthesis disturbance (C20:0, C22:0), and decreased unsaturation (C22:5 n3 and unsat. index), mainly induced by DON and to a lesser extent by ZEA. The DON-FB 1 interaction was additive on C20:0 in liver lipids. In renal phospholipids, ZEA had the strongest effect on the FA profile, affecting the saturated (C18:0) and many n6 FAs; ZEA was in an antagonistic relationship with FB 1 (C18:0) or DON (C18:2 n6, C20:1 n9). Hepatic oxidative stress was the most expressed in FD (reduced glutathione and glutathione peroxidase), while the nephrotoxic effect was further supported by lipid peroxidation (malondialdehyde) in the DON treatment. (4) Conclusions: In vivo study results refer to multiple mycotoxin interactions on membrane FAs, antioxidants and lipid peroxidation compounds, needing further testing.
Introduction
The contamination of cereals with mycotoxins is a worldwide problem. Although the diversity of mycotoxins is enormous, a rather important sub-group is the Fusarium toxins, produced by divergent fungal species of the Fusarium genus. Fusarium mycotoxins are the most frequently occurring mycotoxins worldwide and more specifically fumonisin B 1 (FB 1 ), deoxynivalenol (DON) and zearalenone (ZEA) are the most likely to co-occur [1] [2] [3] [4] [5] .
For the different individual fusariotoxins, the target organs, the mode of toxic action and the physiological indicators have been established in detail. Very briefly, FB 1 has a long-chain hydrocarbon unit, and disturbs or inhibits ceramide synthesis with further, cell membrane homeostasis associated consequences in vertebrates. Besides ceramide, rat hepatic lipids (phospholipid classes and their fatty
Results

Bodyweight and Daily Feed Intake
The initial and final bodyweight (BW), as well as the daily and the total cumulative feed intake were not different among the eight groups, as analyzed with ANOVA and "post hoc" test (Table 1) . Consequently, BW gains, either total (Σ for 14 days) or the daily values, were also not different among the eight groups. No mortality or abnormal symptoms were observed during the trial.
Organ Weights (Absolute and Relative)
As shown in Table 1 , there was a significant difference in the absolute liver weight between the DON and the ZEA groups (DON providing the lower values), but, for all other groups, means were not different from these two or each other. The relative liver weight (percent of body mass) was significantly lower in the DON treated group, as compared to the FB 1 and ZEA as single mycotoxin treatments, and FD and DZ as binary treatment mean values, while the other groups were not different from any of these, as tested with ANOVA. The interaction of the different mycotoxin treatments was evaluated with the Bliss independence method. According to the calculations, there was an antagonistic effect between DON and ZEA on the absolute liver weight. Analyzing DON, its effect on the relative liver weight was antagonistic with that of FB 1 and ZEA, at significant levels in both cases.
The absolute kidney weight was the lowest in the FDZ group, but this was only significantly different from the mean of the ZEA group (Table 1 ). In the relative kidney weight, no inter-group differences were detected, thus, for the mentioned traits, toxin interactions were not considered. The spleen provided a significant difference in its relative weight between DON, and FZ and DZ groups, the latter two providing higher values.
Hepatic Phospholipid Fatty Acid Composition
As analyzed with one-way ANOVA, three individual fatty acids (and unsaturation index, UI) provided inter-group differences (Table 2) in the hepatic phospholipid (PL) fatty acid (FA) profile. Arachidic acid (C20:0) proportion was lower in the FB 1 , DON and FD groups, as compared to the control. Behenic acid (C22:0) proportion was higher in the control group, as compared to the DON and ZEA group mean values, while docosapentaenoic acid (C22:5 n3) proportion was lower in the DON group, as compared to FD. From calculated FA indices, the unsaturation index (UI, the number of double bonds in 100 acyl chains) was significantly lower in the FB 1 and ZEA groups, as compared to the DZ treatment.
When the DON-FB 1 interaction was analyzed on the proportion of arachidic acid, an additive effect was found. FB 1 and ZEA were in synergistic relationship in lowering the UI in the hepatic PL FA profile.
When performing principal component analysis (PCA) on the individual fatty acids (calculated FA variables excluded in the first attempt), there were five (palmitic acid, C16:0; stearic acid, C18:0; linoleic acid, C18:2 n6; arachidonic acid, C20:4 n6 and docosahexaenoic acid, C22:6 n3) FAs with a marked contribution to the variation of the original data (Figure 1a ,b), as described by PC1 along the abscissa. Analyzing the calculated FA indices with PCA, UI was the only component providing a strong contribution (95% of the total) to the variance (not plotted). There was no clear separation of the different mycotoxin treatments found within the PCA score plot (Figure 1a ), but the PC1 loading ( Figure 1b) shows that C16:0, C18:0, C18:2 n6, C20:4 n6, and C22:6 n3 contributed the most to the total variance of the investigated fatty acids of liver.
Kidney Phospholipid Fatty Acid Composition
In the renal total phospholipid FA profile, five individual FAs provided detectable inter-group differences with ANOVA, while no calculated variables were different among groups (Table 3) . As compared to the control, the FD treatment significantly increased the proportion of myristic acid (C14:0). For stearic acid (C18:0), FB 1 provided an increasing effect, as compared to ZEA. Linoleic acid (C18:2 n6) was significantly increased by ZEA, as compared to the DZ treatment, while gamma-linoleic acid (C18:3 n6) was also increased by ZEA, as compared to the control. ZEA further increased the proportion of gondoic acid (C20:1 n9), as compared to the DON and the FD group means.
When the Bliss independence method was applied to elucidate interactions, ZEA and FB 1 were found to act antagonistically on the stearic acid proportion. In the case of gondoic acid, both DON and ZEA were found to act as antagonists, as well as FB 1 and ZEA (FB 1 as a co-occurring factor in the FD treatment).
In the renal PL FA profile, the PC analysis provided a result in which PC1 explained 91.5% of the variation of the individual FA data (Figure 2a) . 
In the renal total phospholipid FA profile, five individual FAs provided detectable inter-group differences with ANOVA, while no calculated variables were different among groups (Table 3) . As compared to the control, the FD treatment significantly increased the proportion of myristic acid (C14:0). For stearic acid (C18:0), FB1 provided an increasing effect, as compared to ZEA. Linoleic acid (C18:2 n6) was significantly increased by ZEA, as compared to the DZ treatment, while gammalinoleic acid (C18:3 n6) was also increased by ZEA, as compared to the control. ZEA further increased the proportion of gondoic acid (C20:1 n9), as compared to the DON and the FD group means.
When the Bliss independence method was applied to elucidate interactions, ZEA and FB1 were found to act antagonistically on the stearic acid proportion. In the case of gondoic acid, both DON and ZEA were found to act as antagonists, as well as FB1 and ZEA (FB1 as a co-occurring factor in the Only four FAs played a determinant role in this, namely palmitic (C16:0), stearic, linoleic and arachidonic acids (Figure 2b ). Analyzing the FA-based indices (separated from the individual FA results), only the UI played a determinant role in determining the variation described by PC1, explaining 95% of the total, similar to the liver. Similar to Figure 1 , there was no clear separation of the different mycotoxin treatments found within the PCA score plot (Figure 2a) , although the three replicates of FB 1 treatment clustered-as indicated with a circle. The PC1 loading (Figure 2b ) shows that C16:0, C18:0, C18:2 n6, and C20:4 n6 contributed the most to the total variance of the investigated fatty acids of kidney. In the renal PL FA profile, the PC analysis provided a result in which PC1 explained 91.5% of the variation of the individual FA data (Figure 2a) . Only four FAs played a determinant role in this, namely palmitic (C16:0), stearic, linoleic and arachidonic acids (Figure 2b ). Analyzing the FA-based indices (separated from the individual FA results), only the UI played a determinant role in determining the variation described by PC1, explaining 95% of the total, similar to the liver. Similar to Figure 1 , there was no clear separation of the different mycotoxin treatments found within the PCA score plot (Figure 2a) , although the three replicates of FB1 treatment clustered-as indicated with a circle. The PC1 loading (Figure 2b ) shows that C16:0, C18:0, C18:2 n6, and C20:4 n6 contributed the most to the total variance of the investigated fatty acids of kidney.
Liver Antioxidant and Oxidative Parameters
In the liver samples, as compared to the control, from the single toxin treatment ZEA, all binary , where PC1 and PC2 is influenced by the multivariate data of the kidney PL fatty acids. PC1 and PC2 explains 86% and 6% of the total variance of the kidney PL fatty acids, respectively (circle is only a visualization aid). (b) Loading bar graph of the PC1 shows the contribution of the individual kidney PL fatty acids to the newly developed latent variable: the higher the loading value, the higher impact of the variance of the respective fatty acid on the variance of PC1.
In the liver samples, as compared to the control, from the single toxin treatment ZEA, all binary combinations (FD, FZ and DZ) significantly increased the reduced glutathione (GSH) concentration (Table 4 ). The ternary combination (FDZ) had an identical effect. In contrast, glutathione peroxidase (GSHPx) activity was increased only by the FD treatment, as compared to the control with ANOVA.
The binary interactions (Bliss independence method) were found to be antagonistic on the level of GSH in the following cases: FB 1 ↔DON, FB 1 ↔ZEA and DON↔ZEA. FB 1 and DON exerted antagonistic effects on the activity of GSHPx. Meanwhile, malondialdehyde (MDA) concentration was not different among groups, when analyzing the antioxidant and lipid peroxidation parameter results with PCA, the only compound providing marked effect on the variance of PC1 was MDA (explained variance: 99.3%; results not plotted).
Kidney Antioxidants and Oxidative Parameters
In the kidney samples, malondialdehyde (MDA) concentration was elevated by the DON treatment, as compared to DZ and FZ. Neither GSH nor GSHPx showed any alteration in the kidney (Table 4 ). The interaction between DON and ZEA was antagonism on the MDA concentration, while between FB 1 and DON it was synergistic, without significance.
Discussion
Bodyweight and Daily Feed Intake
The individual fusariotoxin treatments and their combinations failed to induce any alteration in the feed intake and gross somatic parameters. The 14-day study can be characterized as a mid-term treatment. DON at the applied dose had no detectable effect on feed intake or BW change, while Rotter et al. [17] published that the main effect of DON at dietary concentrations of 12-20 mg/kg feed (ca. 15-fold higher than the present treatment) is the reduction in feed consumption in rats. The applied DON dose (30 µg/kg BW) was equivalent to the mean value of the chronic exposure level defined by the EFSA [18] , ranging between 3.9 and 43.3 µg/kg BW. Since the other mycotoxins or combinations exerted no effect on these traits, their detailed discussion is void, while it is interesting to note that subchronic FB 1 exposure may compromise growth in rats (at 10-fold the present dose [19] ).
Organ Weights (Absolute and Relative)
The difference in the absolute liver weight between the DON and the ZEA groups (DON < ZEA) is a finding that may be explained by the hepatotoxic effect of ZEA in rodents at low mycotoxin concentration (10 µg/kg BW for 14 days) [20] . Similar background may exist for the relative liver weight, adding that relative weight change has a mere hepatic background, since final BW was identical in all groups. Testing lactate dehydrogenase leakage in hepatic cell lines, Wentzel et al. [12] found that ZEA and even FB 1 exert similar, but slight damaging effects. However, the multitoxic arrangements revealed a proven antagonistic effect between DON and ZEA on the absolute liver weight, and also antagonism between DON and FB 1 , ZEA, FD and DZ. This suggests that the two mycotoxins (DON vs. ZEA) exert their toxic action via different interactome sections. Wentzel et al. [12] reported in an in vitro-in silico approach that the expression of tumor suppressor protein 53 gene is down-regulated by FB 1 , as compared to DON and ZEA. This refers to a moderate level of apoptosis and compromised cell metabolism (including ageing) in the FB 1 group. This is also supported by the findings of Gelderblom et al. [6] , when a 21-day FB 1 feeding had a significant effect on rat liver weight only by a 50-fold higher exposure level, as compared to this study. Wentzel et al. [12] stipulated that in vitro the malignant colonization of hepatocytes is occurring through different pathways in a toxin-type dependent manner. Moreover, from the DON-FB 1 -ZEA triplet ZEA was the only mycotoxin that up-regulated the DNA and RNA cytosine deaminase enzyme family and the activation-induced cytidine-deaminase enzyme in Caco-2 cells, referring to associations to cell-to-cell signaling, cell growth and proliferation.
When analyzing the kidney weight (ZEA < FDZ), it can again be hypothesized that ZEA acts differently from DON (A type trichothecene), probably due to the exclusive renal excretion of multiple, hydroxylated metabolites of DON [8] . A similar phenomenon was found for the relative spleen weight: the DON-ZEA interaction on the relative spleen weight was synergistic, with a DON < FZ and DZ difference among the group means. The background of the latter results found in relationship with the action of ZEA may be associated as well with the fact that ZEA [21] and even DON [17] are immunotoxic.
Hepatic Phospholipid Fatty Acid Composition
Arachidic acid (C20:0) proportion was lower in the FB 1 , DON and FD groups, as compared to the control, with a significant DON + FB 1 additive effect because FB 1 and DON attack a quasi-inert fatty acid embedded into the cellular membrane structure that might only be viable if arachidic acid plays some crucial role (being precursor along the FA metabolism) or strictly co-occurs with a biologically (more) active component. The former may be true, since arachidic acid itself is not a major membrane lipid component, but is the precursor of behenic and lignoceric acids (C22:0 and C24:0). In the present work, behenic acid (C22:0) proportion was higher in the control group, as compared to the ZEA treatment. Saturated fatty acids are not sensitive towards lipid peroxidation, but are vital components of ceramides. As earlier reported in a study on rabbits, red cell membrane was markedly depleted in behenic (C22:0) acid by FB 1 [22] . This lowering effect has been explained by the hypothesis that behenic acid is an important component of sphingomyelins, located mostly in the outer leaflet of the membrane bilayer. This fraction is hydrolyzed by the neutral Mg 2+ -dependent sphingomyelinase enzyme to phosphorylcholine and ceramide [23] . Thus, decreasing behenic acid proportion refers to ceramide synthesis inhibition, the characteristic mode of action of FB 1 mycotoxin, as also attained partly in the FB 1 and DON synergism.
Among the polyunsaturated omega-3 FAs, docosapentaenoic acid (C22:5 n3, DPA) was decreased in the DON group, as compared to the FD, while FB 1 and DON were found to act as antagonists in this case. There is no specific toxicological explanation for the DON-induced lowering of the DPA proportion, or fumonisin B 1 , as a DPA increasing factor, but DON has been published to be strongly related to interleukin-6 (IL-6) expression in nephropathy, which has been markedly suppressed by DPA [24] . Interestingly, the IL-6 expression inhibition has been extended later to peritoneal macrophages and further omega-3 FAs, including DHA ( [25] , as also supported by our PCA loading plot results in Figure 1 ).
Kidney Phospholipid Fatty Acid Composition
In the renal total phospholipids, FD treatment significantly increased the myristic acid (C14:0) proportion. Since FB 1 -DON interaction was not found, this result may be a simple toxic effect referring to a slight perturbation of the saturated FAs, synthesized de novo. Although palmitic acid was not responsive, stearic acid (C18:0) proportion increased as an effect of FB 1 , despite the (here appearing) proven FB 1 ↔ZEA interaction (antagonism). The stearate accretion in multiple cellular compartments (which were not separated in our approach) is known: Venkataraman et al. [26] reported in human kidney cells that, as a result of the upstream of growth and differentiation factor 1, the cells continue ceramide synthesis even in the presence of FB 1 , but ceramide is in this case channeled into neutral glycosphingolipids. Authors also confirmed the stearic acid enrichment, which was even further increased by FB 1 . It is thus highly probable that FB 1 induced a saturated FA synthesis, with minor interactions, mostly as a single agent.
From within the n6 FAs linoleic acid (C18:2 n6) proportion was significantly increased by ZEA, as compared to the DZ treatment, while gamma-linoleic acid (C18:3 n6) was as well increased by ZEA, as compared to the control. However, the linoleic acid proportion was only different between the ZEA and the DZ treatment, but DON-ZEA antagonism was not proven. Since linoleic acid is essential, its membrane lipid accretion might be a consequence of its increased dietary uptake, but feed intake was not altered by any of the treatments. Thus, taking as well the gamma-linoleic acid increase into consideration, a slight shift of n6 fatty acid metabolism was hypothesized, which did not influence arachidonic acid proportion. The only supportive data published on the effects of fusariotoxins and linoleic acid refer to the fact that in rat kidney linoleic acid administered with a trichothecene type toxin (Roridin E) augments toxicity via an increased membrane incorporation of both compounds [27] .
However, it was a novel finding that linoleic acid, probably due to its high membrane proportion, played a determinant role in shaping the variance determined by PC1 (Figure 2b ).
Liver Antioxidant and Oxidative Parameters
The tissue concentration of the main, low molecular weight antioxidant, GSH has been increased by ZEA and all binary and the ternary combinations. However, glutathione peroxidase (GSHPx) activity was only different between control and FD, but FB 1 and DON were found to act antagonistically. Based on the above facts, ZEA is the main of the applied three toxins in influencing the glutathione redox system, evoking even the enzymatic defense. This has been first indicated in vitro in Hep G2 cells [28] , describing ZEA as the root compound of oxidative stress. Hassen et al. [28] found that oxidative damage is likely to be evoked as one of the main pathways of ZEA toxicity and may be an initiation to the mechanism of ZEA in its different genotoxic and cytotoxic effects. Our results confirm this finding, since the ultimate product of lipid peroxidation, malondialdehyde was not different among groups; ultimately, ZEA played a hepatotoxic role, of which the extent was compensated by the increase of the non-enzymatic antioxidant (GSH), up to a severity that it already activated antioxidant enzyme response, but remained without cytotoxic end-product (MDA) concentration elevation.
Kidney Antioxidants and oxidative Parameters
The renal oxidation parameters were different from those in the liver, in that DON increased the MDA concentration, as compared to the DZ and FZ; the interaction on MDA between DON and ZEA was antagonistic. To the authors best knowledge this is the first in vivo multitoxin exposure study in which DON has been found to exert defined lipid peroxidation in the renal cortex. The study of Liang et al. [29] revealed that the combination of DON and ZEA exhibited sub-additive, while Kouadio et al. [30] showed more than additive nephrotoxic effect of DON and FB 1 in mice, probably in a species-associated manner. Moreover, in the cited study, the dose of DON was higher and that of FB 1 was lower (45 and 110 µg/kg BW/day, respectively) than in the present one and a shorter exposure period (seven days) was applied. Oxidative stress occurs when oxygen free radical formation exceeds the antioxidant capacity, thus it is rather uncommon that non-enzymatic (GSH) and enzymatic (GSHPx) defense has been not found to be activated, while lipid peroxidation end-product (MDA) concentration increased. It is likely that the enzymatic adaptation of splanchnic organs needs a longer exposure interval.
Conclusions
In a novel in vivo, multitoxic approach, rats were exposed to ZEA, DON and FB 1 , as individual mycotoxins, as well as in their binary and ternary combinations, for 14 days, via gavaging a single toxin bolus per day. Bodyweight was not affected, while absolute liver (ZEA↑ vs. DON) and kidney weight (ZEA↑ vs. FDZ) was modified. The hepatocellular membrane lipid fatty acid profile referred to ceramide synthesis disturbance (C20:0, C22:0), and showed decreased unsaturation (UI), mainly provoked by DON and to a lesser extent by ZEA. In renal phospholipids, ZEA had the strongest effect on the FA profile, affecting stearic acid and most n6 FAs; ZEA was, in most cases, in an antagonistic relationship with FB 1 or DON. Summarizing toxicity, hepatic oxidative stress was the most expressed by the FD treatment, while nephrotoxic effect was proven by malondialdehyde in the DON treatment. Liver phospholipids were the most sensitive on DON (and partially on FB 1 and DON), oxidative stress was mostly induced by FB 1 and DON, while ZEA was affecting organ weight. Renal lipids were affected primarily by ZEA, providing in numerous cases antagonism with FB 1 , while renal lipid peroxidation was mostly provoked by DON. Principal component analysis proved to be effective in the identification of the FAs contributing with the highest relative power to the overall variance. Results refer to multiple and sometimes diverse interactions of the analyzed fusariotoxins, needing further analysis on in vivo models.
Materials and Methods
Animals and Feeding
Adult, male Wistar Crl:WI BR rats (8 weeks of age) were enrolled in the study and were kept in metabolic cages (Tecniplast, Castronno, Italy) individually. The animals (n = 3/group, total n = 24) were fed Ssniff R/M-Z+H feed (Ssniff GmbH, Soest, Germany; Table 5 ). The rats were kept in a 12-h light and 12-h dark daily rhythm, at 20 • C in a rodent room. The relative air humidity was 50%. Feed was offered ad libitum, and feed intake was logged daily (from the daily feed consumption recordings).
The mycotoxins were purchased from Sigma-Aldrich (Schnelldorf, Germany), and stock solutions were prepared with double-distilled water. The solutions contained the daily toxin dose in exactly 1 mL, and this solution was administered as a single gavage dose. For the control animals, 1 mL of double distilled water was dosed. Mycotoxin treatment was set as follows for individual toxins: FB 1 : 150 µg/animal/day, DON: 30 µg/animal/day and ZEA: 15 µg/animal/day, as single gavage boluses, every day at 8:00 AM. The applied doses were pre-determined according the EU limits in finished feed for young pigs (in the absence of limits for rat feed; based on the European Commission Recommendation 2006/576/EC [31] . The toxins binary (FD, FZ, DZ) and ternary (FDZ) mixture meant the same mycotoxin exposure (all mycotoxins in a single, 1 mL aliquot) in an additive manner. The entire treatment lasted for 14 days. After this, animals were sacrificed by cervical dislocation and were immediately exsanguinated and dissected. Total dissected fresh livers and kidneys were weighed immediately and samples were stored frozen (−80 • C) in Eppendorf tubes until analysis. Absolute weight was the fresh total organ weight; relative weight means the organ weight as a percentage of the total BW. The experimental protocol was authorized by the Food Chain Safety and Animal Health Directorate of the Somogy County Agricultural Office, under the permission number SOI/31/1679-11/2014.
Lipid Analysis
Liver and kidney samples of ca. 300 mg were homogenized (IKA T25 Digital Ultra Turrax, Staufen, Germany) in 20-fold volume of chloroform:methanol (2:1 v:v) and total lipid content was extracted according to Folch et al. [32] . Solvents were ultrapure-grade (Sigma-Aldrich, Schnelldorf, Germany) and 0.01 % w:v butylated hydroxytoluene was added to prevent fatty acid oxidation. For the separation of lipid fractions, extracted total lipids were transferred to glass chromatographic columns, containing 300 mg silica gel (230-400 mesh) for 10 mg of total lipids [33] . Neutral lipids were eluted with 10 mL chloroform for the above fat amount, then 15 mL acetone:methanol (9:1 v:v) was added, while 10 mL pure methanol eluted the total phospholipids. This latter fraction was evaporated under a nitrogen stream and was transmethylated with a base-catalyzed NaOCH 3 method [34] . Fatty acid methyl esters were extracted into 250 µL ultrapure n-hexane for gas chromatography, which was performed on a GCMS-QP2010 SE apparatus (AOC 20i automatic injector), equipped with a Phenomenex Zebron ZB-WAX Capillary GC column ( 
Analysis of Lipid Peroxidation
Lipid peroxidation (end-phase) was assessed by the determination of malondialdehyde (MDA) levels using the 2-thiobarbituric acid method from raw tissue samples [35] . The concentration of reduced glutathione (GSH) was measured as non-protein thiols by Ellmann's reagent [36] and the activity of glutathione peroxidase (GSHPx) was determined according to Lawrence and Burk [37] in the 10,000 g supernatant fraction of 1:9 (w:v) tissue homogenate in physiological saline. Protein content of the supernatant was determined with the Lowry method [38] , using Folin phenol reagent. All analyses were performed from tissue samples after storage at −80 • C.
Statistical Analysis
For the comparison of group means of somatic traits (bodyweight (BW), organ weights, relative organ weights and feed intake), fatty acid profile, peroxidation products and antioxidant parameters univariate ANOVA was used with Tukey "post hoc" test, with the SPSS 20 software (2012) [39] . In cases where there existed significant difference between two or multiple groups, the Bliss independence method was applied to ascertain possible, mycotoxin-treatment associated interactions [40] . It is based on the principle that drug effects are outcomes of probabilistic processes and assumes that drugs act independently in such a manner that neither of them interferes with the other (different sites/modes of action), but each contributes to a common result. The observed combination effect expressed as a probability (0 ≤ E AB ≤ 1) can be compared to the expected additive effect given by the common formula for probabilistic independence: E A + E B (1 − E A ) = E A + E B − E A E B , where 0 ≤ E A ≤ 1 and 0 ≤ E B ≤ 1. (Only the significantly existing interaction results are shown in a textual form, merely for the cases where ANOVA also provided significant inter-group differences.) Afterwards, Principal Component Analysis (PCA) was performed on the fatty acid profile of the liver and the kidney, as well as on the blood biochemical parameters with the Unscrambler 9.7. software [41] , to seek principal components describing the variance being responsible for the "group formation" with the highest possible efficacy. The sole purpose of PCA was not to discriminate the certain groups of treatments based on the chemical composition, but to describe the basic orientation of the groups within the multidimensional space described by the variables investigated (e.g., FA profile), and to detect those variables (chemical components, FAs) that have the largest variance compared with the others. The orientation of the samples is described by the score plot showing the scores of each sample along the first two principal components. The variable impact is presented with the loadings bar graph that shows the contribution of the variance of each investigated variable to the variance of the first principal component, i.e., values of the loadings graph are the weights for each original variable when calculating the principal component.
